Jahr Robert Charles Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$149,999.85
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Jahr Robert Charles

According to the SEC Form 4 filings, Jahr Robert Charles, being in a position of

  1. Chief Executive Officer at Outlook Therapeutics, Inc.,
    оver the last 12 months, has bought 151515 shares for $150,000, and sold 0 shares,
    over all time since 2026-08-14, has bought 151515 shares for $150,000, and sold 0 shares.

Biography of Jahr Robert Charles

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $150,0001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-08-14PurchaseOutlook Therapeutics, Inc.
OTLK
Chief Executive Officer
151,515
0.106%
$0.99$150,000-17.61%
Total: 1
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.